Skip to main content

Part of the book series: Current Clinical Practice ((CCP))

Abstract

Knowledge of substance use disorders is essential for health care providers treating pregnant women. Early intervention is vital to improve the health and welfare of both the mother and child. This chapter provides an overview of the consequences and treatments of maternal substance use disorders during pregnancy and breast-feeding. Effective techniques for assessment and intervention are reviewed, as well as psychosocial problems that often accompany maternal substance abuse. Information about various illicit drugs is presented along with strategies for managing withdrawal symptoms. This chapter also outlines potential short- and long-term effects on the child from drug exposure during pregnancy and breast-feeding. Reporting and legal issues are addressed for cases of drug- and/or alcohol-dependent women who present late in pregnancy or who do not respond to available treatments before delivery.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Archie, C. (2002) Substance abuse in pregnancy. In: Pregler, J. P. and De Cherney, A. H., eds. Women’s Health: Principles and Clinical Practice. Hamilton, Ontario: BC Decker Inc., pp. 206–217.

    Google Scholar 

  2. Substance abuse during pregnancy: guidelines for screening (2002) Retrieved March 25, 2005, from Washington State Department of Health website: http://www.doh.wa.gov/cfh/mch/documents/screening_guidelines.pdf

  3. Friedmann, P. D., McCullough, D., and Saitz, R. (2001) Screening and intervention for illicit drug abuse: a national survey of primary care physicians and psychiatrists. Arch. Intern. Med. 161, 248–251.

    Article  PubMed  CAS  Google Scholar 

  4. Foster, K. (2003) Protecting fetal neurons. Retrieved April 14,2005, from Sonoma Medicine website: http://www.scma.org/magazine/scp/Fall03/foster.html

  5. ASI Pregnancy Status National Clearinghouse for Alcohol and Drug Information, P.O. Box 2345, Rockville, MD 20852. 1-800-729-6686.

    Google Scholar 

  6. Pregnant, substance-using women: treatment improvement protocol (TIP) series. (1993) Retrieved April 19, 2005, from Substance Abuse and Mental Health Services Administration. Center for Substance Abuse Treatment website: http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat5.section.22581

  7. Guide to clinical preventive services, 2nd ed. Mental disorders and substance abuse: screening for drug abuse. (1996) Retrieved April 5, 2005, from website: http://cpmcnet.columbia.edu/texts/gcps/gcps0063.html

  8. The National Survey on Drug Use and Health Report. (2004) Pregnancy and substance use. Retrieved March 27, 2005, from website: http://www.drugabusestatistics.samhsa.gov/2k3/pregnancy.htm

  9. The DASIS report: Pregnant Women in Substance Abuse Treatment (2002). Retrieved March 21, 2005, from http://www.drugabusestatistics.samhsa.gov/2k4/pregTX/pregTX.htm

  10. Goldberg, M. E. (1995) Substance-abusing women: false stereotypes and real needs. Soc. Work 40, 789–798.

    PubMed  CAS  Google Scholar 

  11. Wilsnack, S. C., Vogeltanz, N. D., Klassen, A. D. and Harris, T. R. (1997) Childhood sexual abuse and women’s substance abuse: national survey findings. J. Stud. Alcohol 58, 264–271.

    PubMed  CAS  Google Scholar 

  12. Martin, S. L., English, K. T., Clark, K. A., et al. (1996) Violence and substance use among North Carolina pregnant women. Am. J. Psychiatry 86, 991–998.

    CAS  Google Scholar 

  13. Martin, S. L., Beaumont, J. L.K., and Kupper, L. L. (2003) Substance use before and during pregnancy: links to intimate partner violence. Am. J. Drug Alcohol Abuse 29, 599–617.

    Article  PubMed  Google Scholar 

  14. National Institute on Alcohol Abuse and Alcoholism (2005) Retrieved April 28, 2005 from website: http://www.niaaa.nih.gov/press/2005/Recovery.htm.

  15. Floyd, R. L., Decoufle, P., and Hungerford, D. W. (1999) Alcohol use prior to pregnancy recognition. Am. J. Prev. Med. 17, 101–107.

    Article  PubMed  CAS  Google Scholar 

  16. Dufour, M. C., Williams, G. D., Campbell, K. E., et al. (1994) Knowledge of FAS and the risks of heavy drinking during pregnancy, 1985 and 1990. In: Fetal Alcohol Syndrome Prevention Research (Hankin, J. R., August 2002). Retrieved April 9,2005, from NIDA website: http://www.niaaa.nih.gov/publications/arh26-1/58-65.htm

  17. Preventing alcohol-exposed pregnancies: increasing public awareness of the risks of alcohol use during pregnancy through targeted media campaigns. (August 2004) Retrieved April 9, 2005, from website: http://www.cdc.gov/ncbddd/fas/pubawarenss.htm

  18. Gomby, D. and Shiono, P. (1991) Estimating the number of substance-exposed infants. In: Hot Topic: Drug-Exposed Children. Retrieved April 1, 2005, from the National Adoption Information Clearinghouse website: http://www.nurtureadopt.org/af/adoptionarticles/drug-expo sedchildren.htm

  19. Kvigne, V. L., Leonardson, G. R., Neff-Smith, M., et al. (2004) Characteristics of children who have full or incomplete fetal alcohol syndrome. J. Pediatr. 145, 635–640.

    Article  PubMed  Google Scholar 

  20. Jones, K. L., Smith, D. W., Ulleland, C. N., and Streissguth, P. (1973) Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 1, 1267–1271.

    Article  PubMed  CAS  Google Scholar 

  21. Weiner, L. and Morse, B. A. (1988) FAS: clinical perspectives and prevention. In: Chasnoff, I. J., ed. Drugs, Alcohol, Pregnancy and Parenting. Hingham, MA: Kluwer Academic Publishers.

    Google Scholar 

  22. Sokol, R. J. and Clarren, S. K. (1989) Guidelines for use of terminology describing the impact of prenatal alcohol on the offspring. Alcohol Clin. Exp. Res. 13, 597–598.

    Article  PubMed  CAS  Google Scholar 

  23. Michaelis, E. K. and Michaelis, M. L. (2001) Cellular [W1] and molecular bases of alcohol’s teratogenic effects. Retrieved March 23, 2005, from website: http:// www.fetalalcohol.com/articles/docs/Cellmolecular.rtf

  24. Coles, C. (2001) Critical periods for prenatal alcohol exposure: evidence from animal and human studies. Retrieved March 25, 2005, from website: http://www. fetalalcohol.com/articles/docs/CritPeriod.rtf

  25. Rostand, A., Kaminski, M., Lelong, N., et al. (1990) Alcohol use in pregnancy, craniofacial features, and fetal growth. J. Epidemiol. Comm. Health 44, 302–306.

    Article  CAS  Google Scholar 

  26. Danis, R. P., Newton, N., and Keith, L. (1981) Pregnancy and alcohol. Curr. Probl. Obstet. Gynecol. 4, 2–8.

    PubMed  CAS  Google Scholar 

  27. Caruso, K. and Bensel, R. (1993) Fetal alcohol syndrome and fetal alcohol effects. J. Clin. Health Aff. 76, 25–29.

    CAS  Google Scholar 

  28. Streissguth, A. P., Aase, J. M., Clarren, S. K., et al. (1991) Fetal alcohol syndrome in adolescents and adults. JAMA 265, 1961–1967.

    Article  PubMed  CAS  Google Scholar 

  29. Connor, P. D. and Streissguth, A. P. (2001) Effect of prenatal exposure to alcohol across the life span. NIAAA. Retrieved March 10, 2005, from website: http:// www.fetalalcohol.com/articles/docs/PrenatalExposure.rtf

  30. National Center on Birth Defects and Developmental Disabilities (NCBDDD) and Centers for Disease Control and Prevention. Fetal Alcohol Information. Retrieved November 23, 2005, from website: http://www.cdc.gov/ncbddd/fas/fasask.htm

  31. Dolovich, L. R., Addis, A., Vaillancourt, J. M. R., et al. (1998) Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. Br. Med. J. 317, 839–843.

    CAS  Google Scholar 

  32. Ormond, K. and Pergament, E. (1998) Update: Benzodiazepines in pregnancy. Illinois teratogen information services (IT IS) newsletter. Retrieved March 5, 2005, from website: http://www.fetal-exposure.org/BENZOUPDATE.html

  33. Ashton, H. (1995) Toxicity and adverse consequences of benzodiazepine use. Retrieved April 28, 2005, from website: http://www.benzo.org.uk/ashtox.htm.

  34. Gunzerath, L., Faden, V., Zakhari, S., et al. (2004) National Institute on Alcohol Abuse and Alcoholism report on moderate drinking. [editorial] Alcohol. Clin. Exp. Res. 28, 829–847

    PubMed  Google Scholar 

  35. Mennella, J. (2001) Alcohol’s effect on lactation. AlcoholRes. Health 25, 230–234.

    CAS  Google Scholar 

  36. Little R.E., Northstone, K., and Golding, J. (ALSPAC Study Team). (2002) Alcohol, breast-feeding, and development at 18 months. Pediatrics 109, E72.

    Article  PubMed  Google Scholar 

  37. National Organization for the Reform of Marijuana Laws (NORML). (2001) Multidisciplinary Association for Psychedelic Studies (MAPS) Study shows vaporizers reduce toxins in marijuana smoke. (January 2001) Retrieved April 9, 2005, from website: http://www.canorml.org/healthfacts/vaporizerstudy1.html

  38. U.S. Drug Enforcement Administration. Cannabis. Retrieved April 9, 2005, from the DEA website: http://www.usdoj.gov/dea/pubs/abuse/7-pot.htm

  39. Leweke, F. M., Gerth C. W., and Klosterkotter, J. (2004) Cannabis-associated psychosis: current status of research. CNS Drugs 18, 895–910.

    Article  PubMed  Google Scholar 

  40. Verdoux, H., Sorbara, F., Gindre, C., et al. (2003) Cannabis use and dimensions of psychosis in a nonclinical population of female subjects. Schizophr. Res. 59, 77–84.

    Article  PubMed  Google Scholar 

  41. National Survey on Drug Use and Health: pregnancy and substance use (2004) Retrieved on April 21, 2005, from Substance Abuse and Mental Health Services Administration (SAMHSA) website: http://www.oas.samhsa/gov/2k3/pregnancy/pregnancy.pdf

  42. Mathias, R. (January/February 1995) NIDA Survey provides first national data on drug use during pregnancy. Nida Notes 10(1). Retrieved April 9, 2005, from website: http://www.drugabuse.gov/NIDA_Notes/NNVol10N1/NID ASurvey.html

  43. Stocker, S. (March 2000) Marijuana-like compound in womb may influence early pregnancy. Nida Notes 15(1). Retrieved April 9, 2005, from website: http:// www.drugabuse.gov/NID A_Notes/NNVol15N1/M arijuana.html

  44. Fergusson, D. M., Horwood, L. J., and Northstone, K. (2002) Maternal use of cannabis and pregnancy outcome. BJOG Int. J. Obstet. Gynaecol. 109, 21–27.

    Article  Google Scholar 

  45. Fried, P. and Watkinson, B. (1988) 12-and 24-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes and alcohol. Neurotoxicol. Teratol. 10, 305–313.

    Article  PubMed  CAS  Google Scholar 

  46. Day, N., Sambamoorthi, U., Taylor, P., et al. (1991) Prenatal marijuana use and neonatal outcome. Neurotoxicol. Teratol. 13, 329–334.

    Article  PubMed  CAS  Google Scholar 

  47. Day, N., Cornelius, M., Goldschmidt, L., et al. (1992) The effects of prenatal tobacco and marijuana use on offspring growth from birth through three years of age. Neurotoxicol. Teratol. 14, 407–414.

    Article  PubMed  CAS  Google Scholar 

  48. Astley, S. J., Clarren, S. K., Little, R. E., et al. (1992) Analysis of facial shape in children gestationally exposed to marijuana, alcohol, and/or cocaine. Pediatrics 89, 67–77.

    PubMed  CAS  Google Scholar 

  49. Lester, B. M. and Dreher, M. (1989) Effects of marijuana use during pregnancy on newborn cry. Child. Dev. 60, 765-771.

    Google Scholar 

  50. Dreher, M. C., Nugent, K. and Hudgins, R. (1994) Prenatal marijuana exposure and neonatal outcomes in Jamaica: an ethnographic study. Pediatrics 93, 254–260.

    PubMed  CAS  Google Scholar 

  51. Day, N. L. and Richardson, G. A. (2001) Comparative teratogenicity of alcohol and other drugs. Retrieved March 20,2005, from website: http://www.fetalalcohol. com/articles/docs/CompTerat.rtf

  52. Astley, S. J. and Little, R. E. (1990) Maternal marijuana use during lactation and infant development at one year. Neurotoxicol. Teratol. 12(2), 161–188.

    Article  PubMed  CAS  Google Scholar 

  53. Zickler, P. (September 1999) Methamphetamine, cocaine abusers have different patterns of drug use, suffer different cognitive impairments. NIDA Notes 16(5). Retrieved April 15,2005, from website: http://www.drugabuse.gov/NIDA_Notes/ NNVol16N5/Meth_Coc.html

  54. NIDA info facts: crack and cocaine (2005). Retrieved April 9, 2005, from website: http://www.nida.nih.gov/Infofax/Cocaine.html

  55. Pauli, R. M. (December 1996) In depth: cocaine, pregnancy and risk of intrauter-ine death. Newslett. Wisconsin Stillbirth Service Program 3(4). Retreived March 7, 2005, from website: http://www.wisc.edu/wissp/wisspers/dec97001.htm

  56. Addis, A., Moretti, M. E., Ahmed, S. F., et al. (2001) Fetal effects of cocaine: an updated meta-analysis. Reprod. Toxicol. 15, 341–369.

    Article  PubMed  CAS  Google Scholar 

  57. Chiriboga, C. A., Brust, J. C., Bateman, D., et al. (1999) Dose-response effect of fetal cocaine exposure on newborn neurologic function. Pediatrics 103, 79–85

    Article  PubMed  CAS  Google Scholar 

  58. Coles, C. D., Platzman, K. A., Smith, I., et al. (1992) Effects of cocaine and alcohol use in pregnancy on neonatal growth and neurobehavioral status. Neurotoxicol. Teratol. 14, 23–33.

    Article  PubMed  CAS  Google Scholar 

  59. Chiriboga, C. M. (2003) Fetal alcohol and drug effects. Neurologist 9, 267–279.

    Article  PubMed  Google Scholar 

  60. Zickler, P. ( September 1999) NIDA studies clarify developmental effects of prenatal cocaine exposure. NIDA Notes 14(3). Retrieved March 15, 2005, from website: http://www.drugabuse.gov/NIDA_Notes/NNVol14N3/Prenatal.html

  61. Behnke, M., Eyler, F. D., Warner, T. D., et al. (2005) Outcome from a prospective, longitudinal study of prenatal cocaine use: preschool development at 3 years of age. J. Pediatr. Psychol. E-publication.

    Google Scholar 

  62. Methamphetamine/amphetamine. Retrieved April 25, 2005, from the Indiana State Department of Toxicology website: http://isdt.iusm.iu.edu/METHAMPHETAMINE.htm

  63. NIDA research report series — methamphetamine abuse and addiction: what are the immediate effects of methamphetamine abuse? (2005) Retrieved April 12, 2005, from website: http://www.drugabuse.gov/ResearchReports/methamph/methamph3.html#short

  64. Cohen, J. B., Dickow, A., Horner, K., et al. (2003) Abuse and violence history of men and women in treatment for methamphetamine dependence. Am. J. Addict. 12, 377–385.

    Article  PubMed  Google Scholar 

  65. NIDA research report series — methamphetamine abuse and addiction: what is the scope of methamphetamine abuse in the United States? Retrieved April 12, 2005, from website: http://www.drugabuse.gov/ResearchReports/Methamph/methamph2.html#scope

  66. Semple, S. J., Grant, I., and Patterson, T. L. (2004) Female methamphetamine users: social characteristics and sexual risk behavior. Women Health 40, 35–50.

    Article  PubMed  Google Scholar 

  67. Smith, L., Yonekura, M. L., Wallace, T., et al. (2003) Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J. Dev. Behav. Pediatr. 24, 17–23.

    PubMed  Google Scholar 

  68. Mackenzie, R. G. and Heischober, B. (1997) Methamphetamine. Pediatr. Rev. 18, 305–309.

    Article  PubMed  CAS  Google Scholar 

  69. Newton, T. F., Kalechstein, A. D., Duran, S., et al. (2004) Methamphetamine abstinence syndrome: preliminary findings. Am. J. Addict. 13, 248–255.

    Article  PubMed  Google Scholar 

  70. Chang, L., Smith, L. M., LoPresti, C., et al. (2004) Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res. 132, 95–106.

    Article  PubMed  CAS  Google Scholar 

  71. Steiner, E., Villen, T., Hallberg, M., and Rane, A. (1984) Amphetamine secretion in breast milk. Eur. J. Clin. Pharmacol. 27, 123–124.

    PubMed  CAS  Google Scholar 

  72. Pharmacodynamics. Retrieved April 1, 2005, from website: http://www.druglibrary.org/schaffer/heroin/ase/chap_2_1.htm

  73. NIDA info facts: heroin (2004) Retrieved April 9, 2005, from website: http://www.drugabuse.gov/PDF/Infofacts/Heroin.pdf

  74. U.S. Drug Enforcement Administration. Heroin. Retrieved April 9, 2005, from the DEA website: http://www.dea.gov/concern/heroin_factsheet.html#2

  75. Leshner, A. I. (June 2001) Continuing concern over imported pharmaceuticals. Hearing before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, U.S. House of Representatives. Retrieved on March 16, 2005, from the NIDA website: http://www.nida.nih.gov/Testimony/6-7-01Testimony.html

  76. Alcohol and other drug treatment guidelines for pregnant substance-using women: guide-line 4-opioid stabilization. In: Marion, I. J., chair. Pregnant, Substance-Using Women: Treatment Improvement Protocol (TIP) DHHS publication: Series 2 (1993), 18–21.

    Google Scholar 

  77. Broekhuysen, E. S. (April 2000) Methadone. Retrieved March 22, 2005, from the Office of National Drug Control Policy (ONDCP) website: http://www. whitehousedrugpolicy.gov/publications/factsht/methadone/

  78. Berghella, V., Lim, P. J., Hill, M. K., et al. (2003) Maternal methadone dose and neonatal withdrawal. Am. J. Obstet. Gynecol. 189, 312–317.

    Article  PubMed  CAS  Google Scholar 

  79. Finnegan, L.P. and Kandall, S.R. (1997) Maternal and neonatal effects of alcohol and drugs. In:. Lowinson, H. L., Ruiz, P., Milman, R. B., and Langrod, J. G., eds. Substance Abuse: A Comprehensive Textbook. Baltimore: Williams and Wilkins, pp. 513–534.

    Google Scholar 

  80. Jansson, L. M., Velez, M., and Harrow, C. (2004) Methadone maintenance and lactation: a review of the literature and current management guidelines. J. Hum. Lactation 20, 62–71.

    Article  Google Scholar 

  81. The Medical Letter on Drugs and Therapeutics (February 2003) Retrieved April 28, 2005, from website: http://www.medletter.com/freedocs/buprenorphine.pdf

  82. Johnson, R. E., Jones, H. E., and Fischer, G. (2003) Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend. 70, S87–S101.

    Article  PubMed  CAS  Google Scholar 

  83. Johnson, R. E., Jones, H. E., Jasinski, D. R., et al. (2001) Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes. Drug Alcohol Depend. 63, 97–103.

    Article  PubMed  CAS  Google Scholar 

  84. Fischer, G., Johnson, R. E., Eder, H., et al. (2004) Treatment of opioid-dependent pregnant women with buprenorphine. Addiction 95, 239–244.

    Article  Google Scholar 

  85. Clinical guidelines for the use of buprenorphine in pregnancy. (2003) Retrieved April 25, 2005, from website: http://www.turningpoint.org.au/library/CTG_Bup_Pregnancy_060104.pdf

  86. Brady, J. P., Posner, M., Lang, C., and Rosati, M. J. (1994) Risk and reality: the implications of prenatal exposure to alcohol and other drugs. The Education Development Center, Inc. Retrieved, March 21, 2005, from Risk and Reality, a joint project of the U.S. Department of Health and Human Services (DHHS) and the U.S. Department of Education (ED) website: http://www.aspe.hhs.gov/hsp/cyp/ drugkids.htm

  87. Harris, L. H. and Paltrow, A. A. L. (2003) The status of pregnant women and fetuses in US criminal law. JAMA 289, 1697–1699. Retrieved March 28, 2005, from website: http://jama.ama-assn.org/cgi/content/full/289/13/1697#REF-JMS0402-3-1-21

    Article  PubMed  Google Scholar 

  88. Dailard, C. and Nash, E. (December 2000) State responses to substance abuse among pregnant women. The Guttmacher Report on Public Policy 3(6) Retrieved March 23, 2005, from website: http://www.guttmacher.org/pubs/tgr/03/6/ gr030603.html

  89. Dailard, C. and Nash, E. (2000) State responses to pregnant substance abuse among women. The Guttmacher Report on Public Policy 3(6) (see table: Laws Pertaining to Pregnant Women Who Use Drugs). Retrieved March 23, 2005, from website: http://www.guttmacher.org/tables/gr030603t.html

  90. MacMahon J. R. (1997) Perinatal substance abuse: the impact of reporting infants to child protective services. Pediatrics 100(5), E1.

    Article  PubMed  CAS  Google Scholar 

  91. About Us. (2003) National Center on Substance Abuse and Child Welfare. Retrieved March 15, 2005, from SAMHSA website: http://www.ncsacw.samhsa.gov/aboutus.asp

  92. The Impact of Substance Abuse on Foster Care. (February 1999) Retrieved April 25, 2005, from website: http://www.connectforkids.org/articles/substance_abuse_foster_care#theories

  93. Substance Abuse and Child Welfare. Retrieved April 22, 2005, from Children’s Home Society website: http://www.chs-wa.org/2_advsubstanceabuseBACK.htm

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Miotto, K.A., Suti, E., Hernandez, M.M., Pham, P.L. (2006). Pregnancy and Substance Abuse. In: Hendrick, V. (eds) Psychiatric Disorders in Pregnancy and the Postpartum. Current Clinical Practice. Humana Press. https://doi.org/10.1007/978-1-59745-013-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-013-3_7

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-486-9

  • Online ISBN: 978-1-59745-013-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics